Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 1987Journal of Biological ChemistryOpen Access

Cellular metabolism of 2',3'-dideoxycytidine, a compound active against human immunodeficiency virus in vitro.

View Full Paper
Ask AI
Bookmark
Share

Authors

MSM C StarnesDuke UniversityYCYing‐Chih ChengNational Taiwan University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Starnes et al. (1987) studied this question.

synapsesocial.com/papers/6a7fa008044998269cd76fcdhttps://doi.org/10.1016/s0021-9258(19)75738-x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDS1984 · 3,556 citations
  2. 2Lymphadenopathy Associated Virus Infection of a Blood Donor—Recipient Pair with Acquired Immunodeficiency Syndrome1984 · 178 citations
  3. 33'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro.1985 · 1,866 citations
  4. 4Prevalence of Antibodies to Lymphadenopathy-Associated Retrovirus in African Patients with AIDS1984 · 123 citations